{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:30:48Z","timestamp":1790706648481,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejmech.2021.113351","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T01:38:28Z","timestamp":1615081108000},"page":"113351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-7900","authenticated-orcid":false,"given":"Cem","family":"Yamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Uesawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yokose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulilah","family":"Ece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-9602","authenticated-orcid":false,"given":"Halise Inci","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113351_bib1","series-title":"WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All","first-page":"1","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113351_bib2","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.mtbio.2020.100056","article-title":"Rational design and latest advances of codelivery systems for cancer therapy","volume":"7","author":"Meng","year":"2020","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.ejmech.2021.113351_bib3","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113351_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib5","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.bmc.2012.09.062","article-title":"Carbonic anhydrase IX as a target for metastatic disease","volume":"21","author":"Gieling","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/14756366.2019.1697251","article-title":"Carbonic anhydrase IX as a novel candidate in liquid biopsy","volume":"35","author":"Ozensoy Guler","year":"2020","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/14756366.2013.877897","article-title":"Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties","volume":"30","author":"Alafeefy","year":"2015","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib8","doi-asserted-by":"crossref","first-page":"112019","DOI":"10.1016\/j.ejmech.2019.112019","article-title":"Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: design, synthesis, and in\u00a0vitro biological evaluation","volume":"189","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/14756366.2013.827677","article-title":"A\u00a0systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors","volume":"29","author":"Sethi","year":"2014","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib10","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1080\/14756366.2020.1772250","article-title":"Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis","volume":"35","author":"Lorenzo-Pouso","year":"2020","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib11","doi-asserted-by":"crossref","first-page":"83088","DOI":"10.18632\/oncotarget.20236","article-title":"Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113351_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/ijms20020375","article-title":"Investigation of the prognostic role of carbonic anhydrase 9 (CAIX) of the cellular mRNA\/Protein level or soluble CAIX protein in patients with oral squamous cell carcinoma","volume":"20","author":"Eckert","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113351_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.oraloncology.2012.01.018","article-title":"High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma","volume":"48","author":"Brockton","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejmech.2021.113351_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/carcin\/bgw050","article-title":"Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis","volume":"37","author":"Lin","year":"2016","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2021.113351_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14756366.2016.1243536","article-title":"Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib18","doi-asserted-by":"crossref","first-page":"103222","DOI":"10.1016\/j.bioorg.2019.103222","article-title":"Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors","volume":"92","author":"Yamali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bioorg.2018.07.027","article-title":"Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX","volume":"80","author":"Abdel-Aziz","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113351_bib22","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113351_bib24","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib25","doi-asserted-by":"crossref","first-page":"103728","DOI":"10.1016\/j.bioorg.2020.103728","article-title":"Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: synthesis, in\u00a0vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors","volume":"98","author":"Moi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2019.01.002","article-title":"Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors","volume":"85","author":"Sharma","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib27","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3390\/ijms20092354","article-title":"Indole-based hydrazones containing A sulfonamide moiety as selective inhibitors of tumor-associated human carbonic anhydrase isoforms IX and XII","volume":"20","author":"Demir-Yaz\u0131c\u0131","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113351_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bioorg.2017.03.014","article-title":"Carbohydrazones as new class of carbonic anhydrase inhibitors: synthesis, kinetics, and ligand docking studies","volume":"72","author":"Iqbal","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bioorg.2019.02.008","article-title":"Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes","volume":"86","author":"Kucukoglu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib30","first-page":"1","article-title":"Synthesis of potential anticancer effective compounds containing pyrazole-benzensulfonamide moieties, enlightenment of their structures and their cytotoxic activities","author":"Gul","year":"2019","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.ejmech.2021.113351_bib31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3109\/14756366.2016.1140755","article-title":"Carbonic anhydrase inhibition and cytotoxicity studies of Mannich base derivatives of thymol","volume":"31","author":"Gul","year":"2016","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14756366.2016.1221825","article-title":"Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases","volume":"31","author":"Yamali","year":"2016","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib34","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3109\/14756366.2015.1126715","article-title":"The inhibitory effects of phenolic Mannich bases on carbonic anhydrase I and II isoenzymes","volume":"31","author":"Yamali","year":"2016","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib35","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1039\/c2cc33415a","article-title":"Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases","volume":"48","author":"Winum","year":"2012","journal-title":"Chem Commun (Camb)."},{"key":"10.1016\/j.ejmech.2021.113351_bib36","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","article-title":"Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones","volume":"34","author":"Bilginer","year":"2019","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib37","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2174\/1871520618666180525085445","article-title":"Synthesis and cytotoxicities of new azafluorenones with apoptotic mechanism of action and cell cycle analysis","volume":"18","author":"Gul","year":"2018","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib38","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","article-title":"Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides","volume":"31","author":"Gul","year":"2016","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib39","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3109\/14756366.2015.1070263","article-title":"Synthesis of mono Mannich bases of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one and evaluation of their cytotoxicities","volume":"31","author":"Tugrak","year":"2016","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib40","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/1871520617666170327123909","article-title":"Synthesis and cytotoxic activities of difluoro-dimethoxy chalcones","volume":"17","author":"Yamali","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/md15120366","article-title":"Computer-aided drug design applied to marine drug discovery: meridianins as alzheimer\u2019s disease therapeutic agents","volume":"15","author":"Llorach-Pares","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2021.113351_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.sbi.2017.10.010","article-title":"Protein structure-based drug design: from docking to molecular dynamics","volume":"48","author":"Sledz","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2021.113351_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/07391102.2019.1583606","article-title":"Towards more effective acetylcholinesterase inhibitors: a comprehensive modelling study based on human acetylcholinesterase protein-drug complex","volume":"38","author":"Ece","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2021.113351_bib44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/jphp.13269","article-title":"Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti-inflammatory molecule PH46A","volume":"72","author":"Chan","year":"2020","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113351_bib45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/14756366.2014.949256","article-title":"A\u00a0computational insight into acetylcholinesterase inhibitory activity of a new lichen depsidone","volume":"30","author":"Ece","year":"2015","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113351_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/157018010792929612","article-title":"Exploring QSAR on 4-cyclohexylmethoxypyrimidines as antitumor agents for their inhibitory activity of cdk2","volume":"7","author":"Ece","year":"2020","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2021.113351_bib47","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.csbj.2020.06.016","article-title":"Exploring the structural basis of conformational heterogeneity and autoinhibition of human cGMP-specific protein kinase Ialpha through computational modelling and molecular dynamics simulations","volume":"18","author":"Maryam","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2021.113351_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13065-018-0485-3","article-title":"An integrated approach towards the development of novel antifungal agents containing thiadiazole: synthesis and a combined similarity search, homology modelling, molecular dynamics and molecular docking study","volume":"12","author":"Er","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2021.113351_bib49","first-page":"1","article-title":"Synthesis of pyrazol-benzensulfonamide containing anticancer effective compound having cytotoxic activity","author":"Gul","year":"2017","journal-title":"Turk. Pat. Appl."},{"key":"10.1016\/j.ejmech.2021.113351_bib50","first-page":"5299","article-title":"Quantitative structure-cytotoxicity relationship of 3-styryl-2H-chromenes","volume":"35","author":"Uesawa","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2021.113351_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","article-title":"Mordred: a molecular descriptor calculator","volume":"10","author":"Moriwaki","year":"2018","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2021.113351_bib52","series-title":"Small-Molecule Drug Discovery Suite","author":"Schr\u00f6dinger","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113351_bib53","series-title":"LigPrep","author":"Schr\u00f6dinger","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113351_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.113351_bib55","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:26:13Z","timestamp":1759328773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":54,"alternative-id":["S0223523421002002"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113351","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113351"}}